Cargando…
Experimental designs for phase I and phase I/II dose-finding studies
We review the rationale behind the statistical design of dose-finding studies as used in phase I and phase I/II clinical trials. We underline what the objectives of such dose-finding studies should be and why the widely used standard design fails to meet any of these objectives. The standard design...
Autores principales: | O'quigley, J, Zohar, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374235/ https://www.ncbi.nlm.nih.gov/pubmed/16434987 http://dx.doi.org/10.1038/sj.bjc.6602969 |
Ejemplares similares
-
Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development
por: Abd-Rahman, Azrin N., et al.
Publicado: (2022) -
Dose transition pathways: a design, analysis and operational tool for dose-finding trials using model-based designs
por: Yap, Christina, et al.
Publicado: (2015) -
Consequences of Performing Parallel Dose Finding Trials in Heterogeneous Groups of Patients
por: Horton, Bethany Jablonski, et al.
Publicado: (2019) -
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
por: Ursino, Moreno, et al.
Publicado: (2017) -
Predictive Engineering of Class I Terpene Synthases Using Experimental and Computational Approaches
por: Leferink, Nicole G. H., et al.
Publicado: (2021)